Free Trial
OTCMKTS:RBCL

RBC Life Sciences (RBCL) Stock Price, News & Analysis

RBC Life Sciences logo

About RBC Life Sciences Stock (OTCMKTS:RBCL)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.

Receive RBCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RBC Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

RBCL Stock News Headlines

Wave Life Sciences price target raised to $15 from $7 at RBC Capital
RBC Life Science and Technology (0P0001TAGA)
We recommended Nvidia in 2016, now we’re recommending this…
The AI boom is just getting started. And the real wealth has still to be made…
RBC Capital Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)
RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
RBC Mortgage Rates 2024
RBCL RBC Life Sciences, Inc.
RBC Capital Keeps Their Buy Rating on Illumina (ILMN)
See More Headlines

RBCL Stock Analysis - Frequently Asked Questions

Shares of RBCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that RBC Life Sciences investors own include NVIDIA (NVDA), Arcadis (ARCVF), AdvancePierre Foods Holdings, I (APFH), Artisan Partners Asset Management (APAM), American Superconductor (AMSC), ARCAM/SH (AMAVF) and Allison Transmission (ALSN).

Company Calendar

Today
11/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous nondurable goods
Sub-Industry
Wholesale
Current Symbol
OTCMKTS:RBCL
Employees
89
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (OTCMKTS:RBCL) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners